The World Bank Working for a World Free of Poverty Microdata Library
  • Data Catalog
  • About
  • Collections
  • Citations
  • Terms of use
  • Login
    Login
    Home / Central Data Catalog / IMPACT_EVALUATION / CAF_2012_RBFIE-FBL_V01_M / variable [F12]
impact_evaluation

Health Results-Based Financing Impact Evaluation 2012, Health Facility Baseline Survey

Central African Republic, 2012
Get Microdata
Reference ID
CAF_2012_RBFIE-FBL_v01_M
DOI
https://doi.org/10.48529/w8rv-dk07
Producer(s)
Damien de Walque
Collection(s)
Impact Evaluation Surveys Fragility, Conflict and Violence
Metadata
Documentation in PDF DDI/XML JSON
Created on
Oct 17, 2014
Last modified
Jun 16, 2015
Page views
199443
Downloads
66999
  • Study Description
  • Data Description
  • Documentation
  • Get Microdata
  • Data files
  • F1_Aire de
    Santé (section
    15)
  • F1_Disponibilité
    des medicaments
  • F1_Evaluation
    des FOSA
  • F1_Liste des
    personnel(section
    4)
  • F1_Ressource
    humaine
  • F1_Utilisation
    de SNIS(section
    8)
  • F2_Agents de
    santé
  • F3_Oservation
    Directe CPN
  • F4_Observation
    Directe Moins
    de 5ans
  • F5_Sortie de
    CPN
  • F6_Sortie de
    moins de 5ans
  • F7_Sortie Plus
    de 5ans

Type de médicament administrer 1 (f7_02_19_1)

Data file: F7_Sortie Plus de 5ans

Overview

Valid: 268
Invalid: 0
Type: Discrete
Start: 214
End: 235
Width: 22
Range: -
Format: character

Questions and instructions

Literal question
Quel médicament vous a-t-on donné?
Categories
Value Category Cases
1 BUPRFEN 1
0.4%
AAS 1
0.4%
ALBENDAZOL 400mg cp 1
0.4%
ALBENDAZOL 480mg 1
0.4%
ALBENDAZOLE 1
0.4%
ALLUGEL 1
0.4%
AMOXI 5
1.9%
AMOXI 28 CP 1
0.4%
AMOXI 500MG GEL 1
0.4%
AMOXI 500mg 2
0.7%
AMOXICILLINE GEL 1
0.4%
AMPI 1
0.4%
AMPICILINE 3
1.1%
AMPICILLINE 1
0.4%
ARTEMETER 1
0.4%
ARTEMETHER 1
0.4%
ARTHEMETER 1
0.4%
ASPIRINE 1
0.4%
Albendazol 2
0.7%
Alugel 2
0.7%
Amodiaquine 2
0.7%
Amoxi 1
0.4%
Amoxiciline inj 1
0.4%
Amoxicilline 4
1.5%
Amoxicilline 500mg 1
0.4%
Ampi 1g 2
0.7%
Ampiciline 1
0.4%
Ampicillime 2
0.7%
Ampicilline 1
0.4%
Artemether 2
0.7%
Atropine 1
0.4%
Atropine inj 1
0.4%
B12 1
0.4%
BENZATHINE 2
0.7%
BRUFEN 2
0.7%
BRUFFEN 1
0.4%
Betadine bain bouche 1
0.4%
CCL PALU 1
0.4%
CLOXACILLINE 500mg 1
0.4%
COARTEEM 1
0.4%
COARTEM 19
7.1%
COARTEM 24CP 2
0.7%
COARTEM CP 2
0.7%
COARTEME 4
1.5%
COUARTEME 1
0.4%
CTM 2
0.7%
CTM 480mg 1
0.4%
Cimetidine 1
0.4%
Cimétidine inj 1amp 1
0.4%
Ciproflaxacile 1
0.4%
Ciprofloxacilline 1
0.4%
Coartem 5
1.9%
Coartem 20mg 12cp 1
0.4%
DEXA 1
0.4%
DEXA Amp 1
0.4%
DEXA INJ 1amp 1
0.4%
DIASEPHENE 1
0.4%
DIPYROL 1
0.4%
DIPYRONE 2
0.7%
DIPYRONE 1AMP 1
0.4%
DIPYRONE 2.5G 1
0.4%
DYPERONE inj 1
0.4%
DYPIRONE 4
1.5%
Dexa Inj 1
0.4%
Dexamethazone 1
0.4%
Diazepam 1
0.4%
Diclo 1
0.4%
Diclofenac 1
0.4%
Dipyrone 2
0.7%
Dipyrone 1 amp 1
0.4%
Dipyrone 1 ampoule 1
0.4%
Dipyrone inj 3
1.1%
Dypirone 2
0.7%
ERY 500mg 1
0.4%
ERYTHOMYCINE 1
0.4%
EXTENCILLINE 24MINJ 1
0.4%
FANSODAR 1
0.4%
FER 2
0.7%
FILS A SUTURE 1
0.4%
FLAGYL 500mg 2
0.7%
Fol 200mg 1
0.4%
Genta 1
0.4%
Gentamicine 1
0.4%
Gentamicine 1Amp 1
0.4%
H A 2
0.7%
HBB 2
0.7%
HBB INJ 1
0.4%
HEPTAMILE 1
0.4%
IBU 400mg 1
0.4%
IBUPROFEN 1
0.4%
IBUPROFEN 400CP 1
0.4%
Ibuprofen 400 mg 1
0.4%
Ibuprofène 1
0.4%
Indo 1
0.4%
Indo 20cp 1
0.4%
Lame de Bistouri 1
0.4%
Lame de Butours 1
0.4%
METRO 500mg 1
0.4%
METROCLOPRAMIDE 100MG 1
0.4%
MICROGYNON EDFE 1
0.4%
Mebendazol 1
0.4%
Methyldopa 1
0.4%
Oxy 2
0.7%
PARA 4
1.5%
PARACETAMOL 3
1.1%
PARACETAMOL.METRONIDAZ 1
0.4%
PHENO BARBITAL 1
0.4%
POLUGEL 1
0.4%
Para 2
0.7%
Paracetamol 5
1.9%
Paracetamol 500mg 6
2.2%
Paracétamol 2
0.7%
Peni g 1
0.4%
Peni-G 1
0.4%
Prinperon 1
0.4%
Péni G 1
0.4%
QUINIE 400mg 1
0.4%
QUINIMAX 3
1.1%
QUINIMAX 1A 1
0.4%
QUINIMAX 300mg 1
0.4%
QUININE 2
0.7%
QUININE 040 1
0.4%
QUININE500MG 1
0.4%
QX 1
0.4%
QX 0,40MG 1
0.4%
QX INJ 1
0.4%
Quinimax 3
1.1%
Quinimax Inj 1
0.4%
Quinine 2
0.7%
Quinine inj 1
0.4%
Quinine inj. 1
0.4%
Qx 1
0.4%
Qx 400 mg inj 1
0.4%
RIFAMICINE 1
0.4%
Ringer Lactale 1
0.4%
Ringer lactate 1
0.4%
S glucosé plus perfusi 1
0.4%
SERING 2
0.7%
SERUM CITUCOSE EN PERF 1
0.4%
SERUM SALE 1
0.4%
SG 5 1
0.4%
SPARADRAP 1
0.4%
SRO 1
0.4%
Salbutamol 1
0.4%
Sering 1
0.4%
Seringue 10cc 1
0.4%
VIT 1
0.4%
VIT K1 1
0.4%
Xylocaine 1
0.4%
Zentel 1
0.4%
Zylocaïn 2
0.7%
ampiciline 1
0.4%
buscopan 2
0.7%
buscopou 1
0.4%
cipro 1
0.4%
ciproflaxacine 1
0.4%
coart 1
0.4%
coartem 4
1.5%
complexe 1
0.4%
cyproflaxacine 1
0.4%
dexa 1
0.4%
dexa methozone 1
0.4%
diazepam 1
0.4%
diclo 2
0.7%
diclofenac 4
1.5%
dipyrone 1
0.4%
para 500MG 1
0.4%
peni 5mg 1
0.4%
pypirone inj 1
0.4%
quinimax 3
1.1%
quinine 1
0.4%
qx 1
0.4%
qx 040mg 1
0.4%
ringer lactate 1
0.4%
serum glucosé 5% 1
0.4%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Question post text
Enquêteur: vérifiez les médicaments pour confirmation
Back to Catalog
The World Bank Working for a World Free of Poverty
  • IBRD IDA IFC MIGA ICSID

© The World Bank Group, All Rights Reserved.

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.